Skip survey header

BEAT Lung Cancer: Biomarker Testing Survey

Thank you for participating in the BEAT Lung Cancer: Biomarker Testing Survey. Your participation is very important in order to help us learn more about experiences people have with biomarker testing for lung cancer.

This survey is conducted by the Research and Evaluation Group (R&E Group) at Public Health Management Corporation (PHMC) in partnership with the American Lung Association (ALA).

You do not have to respond to questions that you do not want to answer, however, your responses are extremely important to us. All responses and personal health information is protected and will be kept anonymous and used solely for reporting purposes unless otherwise selected by the individual to participate in Biomarker Testing Education and Awareness education opportunities.
1. Are you a lung cancer patient or caregiver?
2. Have you, or the person you care for, received a lung cancer screening prior to being diagnosed with lung cancer?
3. Have you ever received biomarker testing for lung cancer?
3. Has the person you care for ever received biomarker testing for lung cancer?
3. Which biomarker designation did you, or the person you care for, receive?
3. Have you, or the person you care for, ever received targeted therapy for your lung cancer diagnosis?
4. How likely are you to ask your doctor about biomarker testing if you haven't already?
Not likelyNot very likelySomewhat likelyVery likely
5. How much did the BEAT program increase your understanding of biomarker testing?
Not at allA littleSomeA great deal
8. Would you like to receive emails about education and engagement opportunities on biomarker testing from the Lung Association?
This question requires a valid email address.
This question requires a valid number format.
11. Which of the following best describes your race/ethnicity? Select all that apply.
0%